Literature DB >> 16865361

Within-patient variation of the pharmacokinetics of subcutaneously injected biphasic insulin aspart as assessed by compartmental modelling.

W H O Clausen1, A De Gaetano, A Vølund.   

Abstract

AIMS/HYPOTHESIS: Pharmacokinetics of s.c. administered insulin preparations have been widely studied, mostly using descriptive measures such as AUC, time to peak, or the peak plasma concentration. Several compartmental modelling studies of single-bolus s.c. insulin pharmacokinetics have also appeared, with contrasting results regarding the feasibility of insulin pharmacokinetics modelling and the appropriate level of detail for such models. In this paper, we used compartmental models to study the pharmacokinetics of biphasic insulin aspart administered by multiple s.c. injections. The main objective was to assess the magnitude of the inter-and intra-subject variation in the kinetics.
MATERIALS AND METHODS: Analyses were performed on 24-h serum insulin concentrations measured in 20 type 1 diabetes subjects given three daily s.c. injections of biphasic insulin aspart.
RESULTS: Preliminary analysis of the AUC:dose ratio showed that the apparent kinetics are not constant throughout the three daily injections of the compound. A simple and robust compartmental model was shown to be appropriate for interpreting the observations, provided that one of its parameters (the first-order rate constant for transfer from the s.c. depot to plasma) is allowed to vary between injections. CONCLUSIONS/
INTERPRETATION: Population estimates of the chosen model show that intra-subject variations between injections is of the same order of magnitude as inter-subject variation, partially explaining the difficulties encountered when individually tailoring intensified insulin therapy. We conclude that the explicit consideration of a rather simple kinetic model will allow better experimental designs in the future study of s.c. insulin preparations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16865361     DOI: 10.1007/s00125-006-0327-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  21 in total

1.  Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart.

Authors:  L V Jacobsen; B Søgaard; A Riis
Journal:  Eur J Clin Pharmacol       Date:  2000-08       Impact factor: 2.953

2.  Insulin analogs with improved pharmacokinetic profiles.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-02-01       Impact factor: 15.470

3.  Modeling absorption kinetics of subcutaneous injected soluble insulin.

Authors:  E Mosekilde; K S Jensen; C Binder; S Pramming; B Thorsteinsson
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

4.  In vitro and in vivo potency of insulin analogues designed for clinical use.

Authors:  A Vølund; J Brange; K Drejer; I Jensen; J Markussen; U Ribel; A R Sørensen; J Schlichtkrull
Journal:  Diabet Med       Date:  1991-11       Impact factor: 4.359

5.  Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin.

Authors:  Malgorzata E Wilinska; Ludovic J Chassin; Helga C Schaller; Lukas Schaupp; Thomas R Pieber; Roman Hovorka
Journal:  IEEE Trans Biomed Eng       Date:  2005-01       Impact factor: 4.538

Review 6.  Variability of insulin absorption and insulin action.

Authors:  Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2002       Impact factor: 6.118

Review 7.  Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Authors:  A Lindholm; L V Jacobsen
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 8.  Insulin pharmacokinetics.

Authors:  C Binder; T Lauritzen; O Faber; S Pramming
Journal:  Diabetes Care       Date:  1984 Mar-Apr       Impact factor: 19.112

9.  The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.

Authors:  T Kobayashi; S Sawano; T Itoh; K Kosaka; H Hirayama; Y Kasuya
Journal:  Diabetes       Date:  1983-04       Impact factor: 9.461

10.  Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization.

Authors:  Robert T C E Robinson; Nigel D Harris; Robert H Ireland; Anders Lindholm; Simon R Heller
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

View more
  3 in total

1.  Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation.

Authors:  Ahmad Haidar; Claire Duval; Laurent Legault; Rémi Rabasa-Lhoret
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

2.  A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification.

Authors:  Jason Wong; J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Thomas F Lotz; Jessica Lin; Aaron J Le Compte
Journal:  J Diabetes Sci Technol       Date:  2008-07

3.  Pharmacokinetic Model of the Transport of Fast-Acting Insulin From the Subcutaneous and Intradermal Spaces to Blood.

Authors:  Dayu Lv; Sandip D Kulkarni; Alice Chan; Stephen Keith; Ron Pettis; Boris P Kovatchev; Leon S Farhi; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2015-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.